Hoffmann-La Roche Limited
| Specific Topics of Lobbying Communications | Intended Outcomes | Associated Subject Matters |
|---|---|---|
|
Advocacy regarding development of policies to address the public health threat of antimicrobial resistance and policies to encourage innovation in antimicrobial stewardship, surveillance and infection prevention and control.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health, Industry, Science and Technology
|
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Economic Development and Trade, Finances and Budgets, Health
|
|
Engage in discussions involving innovative diagnostics, government support and funding for screening and testing programs to benefit patients in BC, strengthening the diagnostic capability and capacity in the province, and identifying opportunities for partnership.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health, Hospitals, Science and Technology
|
|
Engage in discussions on artificial intelligence innovation and research in British Columbia, and explore opportunities for data sharing and utilizing real world evidence.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health, Hospitals, Science and Technology
|
|
Explore partnership and investment opportunities to support the growth of the life sciences sector in British Columbia.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health, Hospitals, Science and Technology
|
|
Further promote the contributions and positive impact of pharmaceutical innovation and the pharmaceutical industry in British Columbia and to increase awareness of the value of innovative therapies on the healthcare system.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health, Hospitals
|
|
Innovative medicines investment data sharing for clinical trials
|
Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation, Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Economic Development and Trade, Finances and Budgets, Health
|
|
Work with the Ministry of Health regarding public reimbursement of Roche’s innovative pharmaceutical products, and ensure any changes to pharmaceutical legislation support appropriate government reimbursement of innovative pharmaceuticals.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Health, Hospitals
|